Long-term use of carvedilol in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention

β-Blockers and Mortality After Acute Myocardial Infarction in Patients Without Heart Failure or Ventricular Dysfunction

(2017) Tatendashe B. Dondo et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Cardiac and Noncardiac Causes of Long-Term Mortality in ST-Segment–Elevation Acute Myocardial Infarction Patients Who Underwent Primary Percutaneous Coronary Intervention

(2017) Yugo Yamashita et al.   Circulation-Cardiovascular Quality and Outcomes

Effects of β-blockers on left ventricular remodeling in patients with preserved ejection fraction after acute myocardial infarction

(2016) Yu Horiuchi et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

β blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study

(2016) Etienne Puymirat et al.   BMJ-British Medical Journal

β blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study

(2016) Etienne Puymirat et al.   BMJ-British Medical Journal

Meta-Analysis of Relation Between Oral β-Blocker Therapy and Outcomes in Patients With Acute Myocardial Infarction Who Underwent Percutaneous Coronary Intervention

(2015) Bao-Tao Huang et al.   AMERICAN JOURNAL OF CARDIOLOGY

In-hospital outcomes and long-term mortality according to sex and management strategy in acute myocardial infarction. Insights from the French ST-elevation and non-ST-elevation Myocardial Infarction (FAST-MI) 2005 Registry

(2015) Maria Pia Donataccio et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Does Oral Beta-Blocker Therapy Improve Long-Term Survival in ST-Segment Elevation Myocardial Infarction With Preserved Systolic Function? A Meta-Analysis

(2015) Naoki Misumida et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS

Effect of Beta-Blocker Dose on Survival After Acute Myocardial Infarction

(2015) Jeffrey J. Goldberger et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

 -Blockers and Cardiovascular Events in Patients With and Without Myocardial Infarction: Post Hoc Analysis From the CHARISMA Trial

(2014) S. Bangalore et al.  

Association of Beta-Blocker Therapy at Discharge With Clinical Outcomes in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

(2014) Jeong Hoon Yang et al.   JACC-Cardiovascular Interventions

Short- and Long-Term Cause of Death in Patients Treated With Primary PCI for STEMI

(2014) Frants Pedersen et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Meta-analysis: β-Blocker Dose, Heart Rate Reduction, and Death in Patients With Heart Failure

(2013) Finlay A. McAlister   ANNALS OF INTERNAL MEDICINE

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

(2012) et al.   EUROPEAN HEART JOURNAL

β-Blocker Use and Clinical Outcomes in Stable Outpatients With and Without Coronary Artery Disease

(2012) Sripal Bangalore et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction

(2012) Patrick T. O'Gara et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Lack of Effect of Oral Beta-Blocker Therapy at Discharge on Long-Term Clinical Outcomes of ST-Segment Elevation Acute Myocardial Infarction After Primary Percutaneous Coronary Intervention

(2010) Neiko Ozasa et al.   AMERICAN JOURNAL OF CARDIOLOGY